AltRegen
PrivateLast Round
Series A
Nov 19, 2018
Company Overview
AltRegen is a biotechnology company that develops therapeutic interventions for age-related macular degeneration (AMD) by targeting the biophysical properties of Bruch's membrane.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AltRegen Comparables
Compare AltRegen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Breye Therapeutics | 80% | |
| Guangzhou Yinming Biomedical Technology | 78% | |
| Character Biosciences | 77% |
AltRegen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 19, 2018 |
AltRegen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kite Entrepreneurship Foundation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 19, 2018
Raised Series A led by Kite Entrepreneurship Foundation.
AltRegen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AltRegen's valuation, stock price, and market status.
Is AltRegen a public or private company?
AltRegen is a private company.
What is the current stock price of AltRegen?
AltRegen is a private company with no public stock price. Caplight tracks AltRegen's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is AltRegen worth (valuation)?
Valuation information for AltRegen is not publicly available.
Can I buy AltRegen stock?
AltRegen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AltRegen's last funding round?
AltRegen's most recent funding round was Series A on November 19, 2018.
Who are the main investors in AltRegen?
Key investors in AltRegen include Kite Entrepreneurship Foundation.
Will AltRegen IPO soon?
No public IPO plans have been announced for AltRegen.
How can I track AltRegen secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AltRegen's secondary market activity and sign up for updates.